Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings
Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings
Regular price
$20.00 USD
Regular price
$20.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings
Regular price
$20.00
Regular price
$20.00
Sale price
Unit price
per
Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings
Include: 17 videos, size: 3.24 GB
The Updates in Cancer Therapies: A Review of the 2023 ASCO & ESMO Annual Meetings organized by Meetings Events & Conference Coordinators (MECC) is designed to provide a comprehensive overview of the latest advancements in cancer therapies presented at these two major oncology conferences.
Target Audience:
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Oncology nurses
- Advanced registered nurse practitioners
- Oncology pharmacists
- Physician assistants
- Researchers and clinical scientists involved in cancer care
This event focuses on the most significant and practice-changing data from the ASCO and ESMO annual meetings, covering a wide range of cancer types and treatment modalities. It includes presentations, Q&A sessions, and discussions led by key opinion leaders in each cancer field
Topics:
- 2023 ASCO ESMO Updates in Prostate Cancer Combination Therapy becoming the best approach.mp4
Antibody Drug Conjugates in NSCLC.mp4
ASCO and ESMO Updates 2023 Metastatic Breast Cancer.mp4
ASCO ESMO updates.mp4
Current and Emerging Treatments for Patients With HR+ HER2- Early Breast Cancer.mp4
Incidental Gallbladder Cancer Making the case for neoadjuvant therapy.mp4
Modern Challenges and New Options in Lymphoma Treatment.mp4
Most Relevant Data on lmmunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC.mp4
Myeloma A 2024 Perspective Based on what has happened in 2023.mp4
New Developments in CLL.mp4
New Developments in EGFR and K-RAS Therapies in NSCLC.mp4
Novel Frontiers in the Use of cDNA in Oncology.mp4
Updates in Colorectal Cancer.mp4
Updates in Gynecologic Malignancies.mp4
Updates in Kidney and Bladder Cancers Where are we with immunotherapy and precision medicine.mp4
Updates on T-cell lymphomas.mp4
Updates on Targeting ALK, R051, and RET in NSCLC.mp4
